Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Clinical Evidence: Several studies support anecdotal evidence for the potential of BPC-157 in strengthening the immune system: a) A study published in the Journal of Pharmacological Sciences demonstrated that BPC-157 administration improved immune response and reduced inflammation in animal models, suggesting its immunomodulatory effects
Thymosin Beta-4 may treat joint inflammation Even in animal studies, the science on this is not clear
In endometriosis, this mechanism helps reduce adhesion formation, one of the most problematic complications that can cause bowel obstruction, fertility issues, and chronic pain
Pharmacokinetically, BPC-157 has a relatively short plasma half-life estimated at 10-15 minutes when administered parenterally, though its tissue-level effects persist far longer due to receptor-level interactions and growth factor cascading
Only medical- or pharmaceutical-grade peptides prescribed by a qualified physician should be used for therapy.35 As for TB-500, there are unfortunately no studies on its safety
